Skip to content

John Castellani

Latest Stories

20110927-204900-pic-823375978.jpg

20110927-204900-pic-823375978.jpg

BITTER PILL: John Castellani, president and CEO of PhRMA, cautions against cutting from 12 years to seven the length of a patent on a company's new drug. (J.M. Eddins Jr./The Washington Times)